Vaccination against Chlamydia Genital Infection Utilizing the Murine C. muridarum Model
CM Farris, RP Morrison - Infection and immunity, 2011 - Am Soc Microbiol
Chlamydia trachomatis genital infection is a worldwide public health problem, and
considerable effort has been expended on developing an efficacious vaccine. The murine …
considerable effort has been expended on developing an efficacious vaccine. The murine …
Chloroplast‐derived vaccines against human diseases: achievements, challenges and scopes
Infectious diseases represent a continuously growing menace that has severe impact on
health of the people worldwide, particularly in the developing countries. Therefore, novel …
health of the people worldwide, particularly in the developing countries. Therefore, novel …
[HTML][HTML] Vaccine adjuvant properties of probiotic bacteria
PV Licciardi, MLK Tang - Discovery medicine, 2011 - discoverymedicine.com
Vaccine-preventable diseases are still responsible for the deaths of more than 1 million
children under the age of 5 years annually, mostly in developing countries. A substantial …
children under the age of 5 years annually, mostly in developing countries. A substantial …
Archaeosomes with encapsulated antigens for oral vaccine delivery
Z Li, L Zhang, W Sun, Q Ding, Y Hou, Y Xu - Vaccine, 2011 - Elsevier
Traditional phosphodiester lipid vesicles (liposomes) are not stable and could be easily
degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery …
degraded in the gastrointestinal (GI) tract. We prepared a novel lipid based oral delivery …
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors
Chlamydia trachomatis (Ct) is the most common sexually transmitted bacterial pathogen in
the World and there is an urgent need for a vaccine to prevent these infections. To determine …
the World and there is an urgent need for a vaccine to prevent these infections. To determine …
Amphipols stabilize the Chlamydia major outer membrane protein and enhance its protective ability as a vaccine
The native major outer membrane protein (nMOMP) from Chlamydia was purified in its
trimeric form using the zwitterionic detergent Z3-14. In aliquots from this preparation, Z3-14 …
trimeric form using the zwitterionic detergent Z3-14. In aliquots from this preparation, Z3-14 …
Formulation design considerations for oral vaccines
Whilst oral vaccination is a potentially preferred route in terms of patient adherence and
mass vaccination, the ability to formulate effective oral vaccines remains a challenge. The …
mass vaccination, the ability to formulate effective oral vaccines remains a challenge. The …
Nanocarriers for transmucosal vaccine delivery
Immunization has been realized as one of the most cost effective methods of controlling
microbial infections. Currently, the most widely employed means of vaccine delivery …
microbial infections. Currently, the most widely employed means of vaccine delivery …
Vaccination against nicotine alters the distribution of nicotine delivered via cigarette smoke inhalation to rats
M Pravetoni, DE Keyler, MD Raleigh, AC Harris… - Biochemical …, 2011 - Elsevier
Preclinical models of nicotine vaccine pharmacology have relied on iv or sc administration of
nicotine. Models using cigarette smoke inhalation might more accurately simulate nicotine …
nicotine. Models using cigarette smoke inhalation might more accurately simulate nicotine …
Th17 cells contribute to nontypeable Haemophilus influenzae‐specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α …
K Noda, S Kodama, S Umemoto, N Nomi… - Microbiology and …, 2011 - Wiley Online Library
Nasal vaccination is an effective therapeutic means of preventing upper respiratory infection.
Recently, nasal vaccination with P6 outer membrane protein of nontypeable Haemophilus …
Recently, nasal vaccination with P6 outer membrane protein of nontypeable Haemophilus …